Scott G. Davis - 17 Feb 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
President & COO
Signature
/s/ John F. Glenn, as attorney-in-fact
Issuer symbol
EKSO
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
4
Filing time
22 Feb 2022, 18:36:09 UTC
Previous filing
03 Feb 2022
Next filing
26 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +41,158 +112% $0.000000 77,858 17 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired pursuant to a restricted stock units award granted on April 8, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on April 8, 2022.